RNAi quashes polyQ.
作者信息
Caplen Natasha J
出版信息
Nat Med. 2004 Aug;10(8):775-6. doi: 10.1038/nm0804-775.
PMID:15286770
Abstract
摘要
相似文献
1
RNAi quashes polyQ.
Nat Med. 2004 Aug;10(8):775-6. doi: 10.1038/nm0804-775.
2
RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.
Nat Med. 2004 Aug;10(8):816-20. doi: 10.1038/nm1076. Epub 2004 Jul 4.
3
Reduction of Purkinje cell pathology in SCA1 transgenic mice by p53 deletion.
Neurobiol Dis. 2001 Dec;8(6):974-81. doi: 10.1006/nbdi.2001.0444.
4
Biomedicine. Ataxin-1 regulators in the spotlight.
Science. 2003 Jul 4;301(5629):59-60. doi: 10.1126/science.1086311.
5
Spinocerebellar ataxias.
Neurobiol Dis. 2000 Oct;7(5):523-7. doi: 10.1006/nbdi.2000.0346.
6
RNA interference as potential therapy for neurodegenerative disease: applications to inclusion-body myositis?
Neurology. 2006 Jan 24;66(2 Suppl 1):S114-7. doi: 10.1212/01.wnl.0000192310.07041.53.
7
Post-transcriptional gene silencing in neurons.
Curr Opin Neurobiol. 2004 Oct;14(5):654-9. doi: 10.1016/j.conb.2004.08.009.
8
Senseless makes sense for spinocerebellar ataxia-1.
Nat Neurosci. 2005 Nov;8(11):1422-4. doi: 10.1038/nn1105-1422.
9
Neurodegeneration in the polyglutamine diseases: Act 1, Scene 1.
Nat Neurosci. 2000 Feb;3(2):103-4. doi: 10.1038/72042.
10
Therapeutic potential of small interfering RNA for central nervous system diseases.
Arch Neurol. 2005 Dec;62(12):1810-3. doi: 10.1001/archneur.62.12.1810.
Zotero 插件